510(k) K193115
K193115 is an FDA 510(k) premarket notification submitted by Euroimmun Us, Inc. for the device "EUROIMMUN Anti-BP230-CF ELISA (IgG)". The FDA issued a decision of Substantially Equivalent on Sep 17, 2020. The device falls under product code OEG (Autoantibodies, Skin (Bullous Pemphigoid 180 And Bullous Pemphigoid 230), a Class II device regulated under 21 CFR 866.5660. Euroimmun Us, Inc. has 36 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 17, 2020
- Date Received
- Nov 12, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Autoantibodies, Skin (Bullous Pemphigoid 180 And Bullous Pemphigoid 230
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type
- 510(k)
The device is intended as an aid in the diagnosis of bullous pemphigoid.
Need the full FDA record for Euroimmun Us, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.